- Home
- DSGX vs RGEN Comparison
DSGX vs RGEN Comparison
Compare DSGX & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGX
- RGEN
- Stock Information
- Founded
- DSGX 1981
- RGEN 1981
- Country
- DSGX Canada
- RGEN United States
- Employees
- DSGX N/A
- RGEN N/A
- Industry
- DSGX Computer Software: Prepackaged Software
- RGEN Medical/Dental Instruments
- Sector
- DSGX Technology
- RGEN Health Care
- Exchange
- DSGX Nasdaq
- RGEN Nasdaq
- Market Cap
- DSGX 8.5B
- RGEN 8.2B
- IPO Year
- DSGX 1999
- RGEN N/A
- Fundamental
- Price
- DSGX $100.13
- RGEN $141.40
- Analyst Decision
- DSGX Buy
- RGEN Buy
- Analyst Count
- DSGX 11
- RGEN 10
- Target Price
- DSGX $102.27
- RGEN $188.38
- AVG Volume (30 Days)
- DSGX 133.4K
- RGEN 783.2K
- Earning Date
- DSGX 09-04-2024
- RGEN 10-29-2024
- Dividend Yield
- DSGX N/A
- RGEN N/A
- EPS Growth
- DSGX 13.00
- RGEN N/A
- EPS
- DSGX 1.48
- RGEN N/A
- Revenue
- DSGX $607,697,000.00
- RGEN $602,354,000.00
- Revenue This Year
- DSGX $8.59
- RGEN $0.08
- Revenue Next Year
- DSGX $3.88
- RGEN $12.97
- P/E Ratio
- DSGX $66.99
- RGEN N/A
- Revenue Growth
- DSGX 15.40
- RGEN N/A
- 52 Week Low
- DSGX $69.59
- RGEN $110.45
- 52 Week High
- DSGX $104.71
- RGEN $211.13
- Technical
- Relative Strength Index (RSI)
- DSGX 56.73
- RGEN 42.05
- Support Level
- DSGX $94.56
- RGEN $138.80
- Resistance Level
- DSGX $97.64
- RGEN $150.72
- Average True Range (ATR)
- DSGX 2.17
- RGEN 4.86
- MACD
- DSGX 0.15
- RGEN -0.95
- Stochastic Oscillator
- DSGX 81.02
- RGEN 12.96
About DSGX Descartes Systems Group Inc. (The)
Descartes Systems Group provides a software solution that allows users in the shipping industry to communicate with one another. Its core product is the Global Logistics Network, which is best understood as transaction-driven. Descartes charges clients to send/receive messages, data, and documents on the GLN. Customers typically contract for a monthly minimum over a multiyear period. The GLN platform allows Descartes to upsell additional software modules as well, typically provided via a software-as-a-service model.
About RGEN Repligen Corporation
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.